A randomised phase III trial of focal fractionated conformal stereotactic boost following conventional radiotherapy of high grade gliomas
ISRCTN | ISRCTN37123666 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN37123666 |
ClinicalTrials.gov number | NCT00003916 |
Secondary identifying numbers | E164/8 (BR10) |
- Submission date
- 06/04/2000
- Registration date
- 06/04/2000
- Last edited
- 20/09/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Miss Sally Stenning
Scientific
Scientific
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
ss@ctu.mrc.ac.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | A randomised phase III trial of focal fractionated conformal stereotactic boost following conventional radiotherapy of high grade gliomas |
Study objectives | To determine the effect of a stereotactic boost of radiotherapy on the survival time of patients with high-grade gliomas. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cancer |
Intervention | The trial is designed to randomise patients between two treatment arms: 1. Conventional radiotherapy 2. Conventional radiotherapy plus a stereotactic boost |
Intervention type | Other |
Primary outcome measure | Survival and quality of life. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/04/1999 |
Completion date | 07/12/2001 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 65 Years |
Sex | Not Specified |
Target number of participants | 605 |
Key inclusion criteria | 1. Histologically confirmed gliomas World Health Organisation (WHO) III/IV, no previous histology of low grade tumours WHO I/II 2. Tumour volumes less than 4.0 cm 3. No tumours in brain stem or infratentorial location, no multifocal gliomas 4. Ability to treat tumour safely by stereotactic radiotherapy 5. Eastern Cooperative Oncology Group (ECOG)/World Health Organisation (WHO) performance status 0-2 6. Patient able to tolerate full course of conventional radiotherapy 7. Prior neurosurgery within 6 weeks of randomisation 8. Aged greater than 18 and less than 65 years 9. Informed consent 10. No prior chemo- or radiotherapy |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/04/1999 |
Date of final enrolment | 07/12/2001 |
Locations
Countries of recruitment
- Australia
- England
- France
- Germany
- Netherlands
- Spain
- Switzerland
- United Kingdom
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
Medical Research Council (MRC) (UK)
Research council
Research council
20 Park Crescent
London
W1B 1AL
United Kingdom
Phone | +44 (0)20 7636 5422 |
---|---|
clinical.trial@headoffice.mrc.ac.uk | |
Website | http://www.mrc.ac.uk |
Funders
Funder type
Research council
Medical Research Council (MRC) (UK)
Government organisation / National government
Government organisation / National government
- Alternative name(s)
- Medical Research Council (United Kingdom), UK Medical Research Council, MRC
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Other publications | article | 01/04/1999 | Yes | No | |
Results article | results | 01/08/2008 | Yes | No |
Editorial Notes
20/09/2017: Publication reference added.